Karthik and her team aimed to use CRISPR as a way to identify and isolate a protein generated by the bacteria that cause Lyme ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Medra, which programs robots with artificial intelligence to conduct and improve biological experiments, has raised $52 million to build what it says will be one of the largest autonomous labs in the ...
Investing.com -- Medra, a company that programs robots with artificial intelligence to conduct biological experiments, has raised $52 million to build what it claims will be one of the largest ...
Equity Insider News Commentary ? Traditional pharmaceutical strategies are giving ground as breakthrough approvals for gene therapies and mRNA platforms target previously untreatable rare diseases ...
Innovation cycles are shifting at a remarkable pace. Artificial intelligence, biotechnology and clean energy systems now influence how nations design public pol ...
Epicrispr Biotechnologies, a clinical-stage company pioneering gene-modulating therapies, today announced that Amber Salzman, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P.
Morning Overview on MSN
Programmable CRISPR cuts stem cell timing from months to weeks
Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
On Jan. 23, hundreds of couples in Bangkok tied the knot in a mass wedding ceremony after a 2024 bill recognizing same-sex ...
At Korea Institute of Science and Technology (KIST), where research areas include materials, robotics and artificial intelligence, the team within its CJLab function were involved in Cas9 research.
They want to escape from regulation and ‘failing’ democracy — but are they more opportunistic than libertarian?
When you look at the big players in medical tech, Siemens Healthineers definitely stands out as a major competitor to GE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results